Cancer-related systemic inflammation activates pro-inflammatory cytokines, including interleukin (IL)-1, IL-6, and tumor necrosis factor alpha, which suppress appetite by acting on the hypothalamus and contribute to catabolic processes, including muscle degradation and lipolysis [17, 18]. Here, IL6 is linked to cancer.